Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Altimmune (ALT) over the last 13 years, with Sep 2025 value amounting to -$149.3 million.

  • Altimmune's Cash from Investing Activities fell 12553.79% to -$149.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.7 million, marking a year-over-year increase of 20.60%. This contributed to the annual value of -$28.4 million for FY2024, which is 306.71% down from last year.
  • According to the latest figures from Q3 2025, Altimmune's Cash from Investing Activities is -$149.3 million, which was down 247.69% from $101.1 million recorded in Q2 2025.
  • Altimmune's 5-year Cash from Investing Activities high stood at $101.1 million for Q2 2025, and its period low was -$149.3 million during Q3 2025.
  • For the 3-year period, Altimmune's Cash from Investing Activities averaged around -$6.2 million, with its median value being $1.2 million (2024).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first skyrocketed by 147,900.00% in 2023, then plummeted by 12,553.79% in 2025.
  • Altimmune's Cash from Investing Activities (Quarterly) stood at $24.9 million in 2021, then tumbled by 96.06% to $981,000 in 2022, then crashed by 911.31% to -$8.0 million in 2023, then spiked by 271.28% to $13.6 million in 2024, then tumbled by 12,553.79% to -$149.3 million in 2025.
  • Its Cash from Investing Activities was -$149.3 million in Q3 2025, compared to $101.1 million in Q2 2025 and -$5.1 million in Q1 2025.